Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35
Closed -$16 2157
2025
Q2
$16 Hold
35
﹤0.01% 1962
2025
Q1
$13 Hold
35
﹤0.01% 1923
2024
Q4
$23 Hold
35
﹤0.01% 1937
2024
Q3
$29 Hold
35
﹤0.01% 1861
2024
Q2
$24 Buy
+35
New +$29 ﹤0.01% 1884
2024
Q1
Sell
-35
Closed -$27 1953
2023
Q4
$27 Hold
35
﹤0.01% 1688
2023
Q3
$35 Hold
35
﹤0.01% 1680
2023
Q2
$34 Hold
35
﹤0.01% 1721
2023
Q1
$36 Hold
35
﹤0.01% 1719
2022
Q4
$44 Hold
35
﹤0.01% 1681
2022
Q3
$102 Hold
35
﹤0.01% 1679
2022
Q2
$169 Hold
35
﹤0.01% 1703
2022
Q1
$228 Hold
35
﹤0.01% 1735
2021
Q4
$291 Buy
+35
New +$239 ﹤0.01% 1702

Other funds holding VXRT

TD Waterhouse Canada's VXRT Position: Q3 2025 in Review

TD Waterhouse Canada sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 35 shares — an estimated $16 sold.

TD Waterhouse Canada first reported a position in VXRT in Q4 2021 and held it in 14 quarters. The position peaked at $291 in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • TD Waterhouse Canada reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 35 Vaxart shares in Q3 2025, an estimated $16.
  • TD Waterhouse Canada first reported a position in Vaxart in Q4 2021 and held it in 14 quarters.
  • TD Waterhouse Canada's Vaxart position peaked at $291 in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on TD Waterhouse Canada's 13F filing for Q3 2025, filed 3 Nov 2025.